Dyne Therapeutics, Inc.
NASDAQ:DYNBiotechnology
Healthcare
$16.03 +1.97%
+$0.38 today
- Market cap
- $3.00B
- Beta
- 1.08
- P/E (TTM)
- -7.2
- EPS (TTM)
- -$2.74
52W Low $8.06High $25.00
Volume 2.44M
Average 1.71M
Price history
Dyne Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-20.33%
Period high
$26.78
Period low
$14.25
Latest
$16.03
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Oct 22, 2026 | Oct 22, 2026 | |
| 4 | Oct 6, 2026 | Oct 6, 2026 | |
| 8-K | Sep 29, 2026 | Sep 29, 2026 | |
| 4 | Sep 8, 2026 | Sep 8, 2026 | |
| 4 | Sep 8, 2026 | Sep 8, 2026 | |
| 4 | Sep 8, 2026 | Sep 8, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| 4 | Aug 17, 2026 | Aug 17, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 |
Competitors
Who does Dyne Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about DYN's filings, answered from its disclosures.
What is the latest DYN filing?
The latest filing shown is 10-Q dated Nov 5, 2026.
How many recent filings does DYN have?
Intrinsic Alpha currently shows 20 recent filings for DYN.
Continue the stock analysis
Jump to another research area for this company.